Fred Van Leuven
Leuven, VLG 3000, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Unraveling the Effects of GSK-3β Isoform Modulation against Limbic Seizures and in the 6 Hz Electrical Kindling Model for Epileptogenesis.
Journal: ACS chemical neuroscience
Published: March 07, 2022
Annexin A1 restores cerebrovascular integrity concomitant with reduced amyloid-β and tau pathology.
Journal: Brain : a journal of neurology
Published: July 10, 2020
Quantitative Assessment of Age-Associated Alterations in Brain Vasculature in Wild-Type Mice and in Bigenic Mice that Model Alzheimer's Disease.
Journal: Molecular imaging and biology
Published: July 13, 2019
Regional vulnerability and spreading of hyperphosphorylated tau in seeded mouse brain.
Journal: Neurobiology of disease
Published: October 29, 2018
Identification of GSK-3 as a Potential Therapeutic Entry Point for Epilepsy.
Journal: ACS chemical neuroscience
Published: October 24, 2018
TauBI or not TauBI: what was the question?
Journal: Brain : a journal of neurology
Published: September 01, 2018
GSK3β activity alleviates epileptogenesis and limits GluA1 phosphorylation.
Journal: EBioMedicine
Published: August 29, 2018
Deficiency in the transcription factor NRF2 worsens inflammatory parameters in a mouse model with combined tauopathy and amyloidopathy.
Journal: Redox biology
Published: May 18, 2018
Longitudinal assessment of cerebral perfusion and vascular response to hypoventilation in a bigenic mouse model of Alzheimer's disease with amyloid and tau pathology.
Journal: NMR in biomedicine
Published: January 30, 2018
GSK3β Controls mTOR and Prosurvival Signaling in Neurons.
Journal: Molecular neurobiology
Published: June 08, 2017
Last Updated: 09/26/2026